China Universal Asset Management Raises Stake in GenFleet Therapeutics-B with Purchase of 299,600 Shares at HK$23.44 Each

Stock News11-04

According to the latest data from the Hong Kong Stock Exchange, China Universal Asset Management increased its holdings in GenFleet Therapeutics-B (ASX: 02595) by 299,600 shares on October 30, at a price of HK$23.4445 per share, for a total consideration of approximately HK$7.024 million.

Following the increase, China Universal Asset Management's latest holding stands at 17.7748 million shares, representing a 5.05% stake in the company.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment